Literature DB >> 15739191

Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures.

Ainara Vallejo-Illarramendi1, Mónica Torres-Ramos, Marcello Melone, Fiorenzo Conti, Carlos Matute.   

Abstract

To test the hypothesis that clozapine-induced reduction of glutamate transporter-1 (GLT-1) expression is mediated by astrocytes, we studied the effects of clozapine on Glu transporters and Glu uptake in primary astrocyte cultures of the cerebral cortex. Astrocyte cultures treated for 48 h with clozapine exhibited a reduction in GLT-1 levels of about 50%, whereas glutamate-aspartate transporter (GLAST) levels remained unchanged. Glu uptake was also lowered, and this reduction was dose-dependent. Our findings indicate that clozapine reduces GLT-1 expression and function by a mechanism that directly involves astrocytes. A better understanding of the molecular events by which antipsychotics regulate Glu uptake can contribute to identify new targets for the treatment of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15739191     DOI: 10.1002/glia.20172

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  13 in total

1.  Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer's Disease Model.

Authors:  Eliezer Joseph; Daniel Miguel Ángel Villalobos-Acosta; Mónica Adriana Torres-Ramos; Eunice Dalet Farfán-García; Modesto Gómez-López; Ángel Miliar-García; Manuel Jonathan Fragoso-Vázquez; Iohanan Daniel García-Marín; José Correa-Basurto; Martha Cecilia Rosales-Hernández
Journal:  J Mol Neurosci       Date:  2019-11-25       Impact factor: 3.444

Review 2.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

3.  Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.

Authors:  Marco Matos; Hai-Ying Shen; Elisabete Augusto; Yumei Wang; Catherine J Wei; Yu Tian Wang; Paula Agostinho; Detlev Boison; Rodrigo A Cunha; Jiang-Fan Chen
Journal:  Biol Psychiatry       Date:  2015-02-27       Impact factor: 13.382

Review 4.  Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.

Authors:  P M Beart; R D O'Shea
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

5.  Clozapine induces astrocyte-dependent FDG-PET hypometabolism.

Authors:  Andréia Rocha; Bruna Bellaver; Débora G Souza; Guilherme Schu; Igor C Fontana; Gianina T Venturin; Samuel Greggio; Fernanda U Fontella; Manoela L Schiavenin; Luiza S Machado; Diogo Miron; Jaderson C da Costa; Pedro Rosa-Neto; Diogo O Souza; Luc Pellerin; Eduardo R Zimmer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-05       Impact factor: 10.057

6.  The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats.

Authors:  Michele Bellesi; Fiorenzo Conti
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

7.  Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds.

Authors:  Nader D Halim; Barbara K Lipska; Thomas M Hyde; Amy Deep-Soboslay; E Michael Saylor; Mary M Herman; Jay Thakar; Ajay Verma; Joel E Kleinman
Journal:  J Neurosci Methods       Date:  2007-11-29       Impact factor: 2.390

Review 8.  Antipsychotic treatment modulates glutamate transport and NMDA receptor expression.

Authors:  Mathias Zink; Susanne Englisch; Andrea Schmitt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-12       Impact factor: 5.270

Review 9.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

10.  Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.

Authors:  Beatriz Moreno; Iciar Lopez; Begoña Fernández-Díez; Miroslav Gottlieb; Carlos Matute; María Victoria Sánchez-Gómez; María Domercq; Albert Giralt; Jordi Alberch; Kevin W Collon; Helen Zhang; Jack M Parent; Meritxell Teixido; Ernest Giralt; Valentín Ceña; Inmaculada Posadas; Eva Martínez-Pinilla; Pablo Villoslada; Rafael Franco
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.